This post summarises what we know (so far) about Lineage B.1.617, the so-called "double mutant" COVID-19 variant first discovered in India in October last year. Of particular concern are two questions - is it responsible for the rapid escalation of the virus in India, and are vaccines effective against it.
With five covid-19 vaccines already deployed, and over 200 in development, an individual may be able to choose more than one of these - once the initial backlog is cleared. There have been no scientific studies on whether such an action would provide greater immunity, but it is generally believed it would - not unlike the booster shots which are already being given in more familiar vaccines.
This is a useful page on the CDC website which provides the records of past incidents where apparent side-effects were linked to the vaccine. The study in most cases showed no correlation.
Scientists have successfully restored vision in old mice by tweaking their DNA and regenerating cells to make them "younger". This experiment could have implications for humans, and the process has already been licenced by Harvard to a Life Sciences company in their city (Boston).
IBM analysts have found evidence of a large scale hacking operation targeting the covid-19 vaccine supply chain. It has the bearings of a state-directed operation.
UK based AI company DeepMind (acquired by Google in 2014) was best known for its AlphaZero program which became a world champion at Chess and Go. Now, its AlphaFold program has cracked a biology problem, which could revolutionise medicine and cure diseases